This study aims to evaluate the extent to which the BTS/NICE clinical standards for the diagnosis and management of CAP in adults are currently implemented in UK primary care, specifically evaluating:
(i) The recording of the CRB65 at the time of CAP diagnosis in primary care patients
(ii) Evaluate antibiotic prescribing patterns at the time of CAP diagnosis in primary care.
The objective of the work is to improve understanding current clinical practice behaviours with a view to assessing the feasibility and scale of practice change required to implement the BTS/NICE recommendations diagnosis and management of CAP moving forward.
Chris Winchester: Chief Executive Officer of Oxford Pharmagenesis, Oxford, UK
David Price, Professor of Primary Care Respiratory Medicine, University of Aberdeen, Aberdeen, UK; Owner of Optimum Patient Care Ltd and REG Chairman
Alison Chisholm: Chief Scientific Officer of REG, Cambridge, UK
Anjan Nibber: Researcher, Research in Real Life on behalf of REG, Cambridge, UK
Status: Active Study
Documents and Publications